Light Mode
$1.90 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.90, $0.05 below the day’s high of $1.95
-1.09 (-36.70%) / 6M
Momentum, market sentiment, and recent alerts
GNLX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -68.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay on September 4, 2001 and is headquartered in Westlake Village, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.